PATENT CLAIM ANALYSIS

Application Number: 15772455
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "547000"]

Abstract:
The present invention relates to pharmaceutical composition comprising dimethyl fumarate; an enzyme modulator or a permeation enhancer or both; and one or more pharmaceutically acceptable excipients. It further relates to a pulsatile release pharmaceutical composition comprising dimethyl fumarate and one or more pharmaceutically acceptable excipients. The compositions of the present invention are administered at a lower dose as compared to the recommended daily dose of Tecfidera®. Further, the compositions of the present invention are resistant to dose dumping in the presence of alcohol.

Claim (Index 20):
The pharmaceutical composition according to  claim 19 , wherein the low dose is about 432 mg per day, about 408 mg per day, about 384 mg per day, about 360 mg per day, about 336 mg per day, about 312 mg per day, or about 288 mg per day.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 91.0
- Lexical Diversity: 1.8
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15299535', '15386175', '15170421', '15248506', '15582913']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8083499481825762
- 35 USC 102 Novelty (BERT): 0.5231337533213928
- Combined Prediction Score: 0.7798283286964579
- Mean Citation Score: 307.076842
- Max Citation Score: 314.52646
- Similarity Product: 200.3288225344348

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test